Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer

Robert Michael Kwee*, Thomas Christian Kwee

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Web of Science)


With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer, there has come a need to discriminate responders from non-responders. In this article, the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.
Original languageEnglish
Pages (from-to)1650-1656
JournalWorld Journal of Gastroenterology
Issue number7
Publication statusPublished - 21 Feb 2014


  • Gastric cancer
  • Neoadjuvant therapy
  • Chemotherapy
  • Response
  • Imaging

Cite this